These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 8169822)
1. Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967. Mishra SK; Hermsmeyer K J Pharmacol Exp Ther; 1994 Apr; 269(1):178-83. PubMed ID: 8169822 [TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967). Bezprozvanny I; Tsien RW Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636 [TBL] [Abstract][Full Text] [Related]
3. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries. Bian K; Hermsmeyer K Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155 [TBL] [Abstract][Full Text] [Related]
5. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells. Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil. Hefti F; Clozel JP; Osterrieder W Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242 [TBL] [Abstract][Full Text] [Related]
7. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel. Lacinová L; Welling A; Bosse E; Ruth P; Flockerzi V; Hofmann F J Pharmacol Exp Ther; 1995 Jul; 274(1):54-63. PubMed ID: 7616442 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil. Aczél S; Kurka B; Hering S Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326 [TBL] [Abstract][Full Text] [Related]
9. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells. Gomora JC; Xu L; Enyeart JA; Enyeart JJ J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935 [TBL] [Abstract][Full Text] [Related]
10. Mibefradil, a pharmacologically distinct calcium antagonist. Ernst ME; Kelly MW Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells. Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376 [TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein. Liu H; Sperelakis N Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814 [TBL] [Abstract][Full Text] [Related]
13. Effects of the Ca2+ antagonist RO 40-5967 on endothelium-dependent responses of isolated arteries. Boulanger CM; Nakashima M; Olmos L; Joly G; Vanhoutte PM J Cardiovasc Pharmacol; 1994 Jun; 23(6):869-76. PubMed ID: 7523777 [TBL] [Abstract][Full Text] [Related]
14. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells. Matsuoka T; Nishizaki T; Nomura T Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of myricetin stimulation of vascular L-type Ca2+ current. Fusi F; Sgaragli G; Saponara S J Pharmacol Exp Ther; 2005 May; 313(2):790-7. PubMed ID: 15665142 [TBL] [Abstract][Full Text] [Related]
16. Effects of nitric oxide donors, S-nitroso-L-cysteine and sodium nitroprusside, on the whole-cell and single channel currents in single myocytes of the guinea-pig proximal colon. Lang RJ; Watson MJ Br J Pharmacol; 1998 Feb; 123(3):505-17. PubMed ID: 9504392 [TBL] [Abstract][Full Text] [Related]
17. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5. Perchenet L; Clément-Chomienne O J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117 [TBL] [Abstract][Full Text] [Related]
18. Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts. Liu JH; Bijlenga P; Occhiodoro T; Fischer-Lougheed J; Bader CR; Bernheim L Br J Pharmacol; 1999 Jan; 126(1):245-50. PubMed ID: 10051142 [TBL] [Abstract][Full Text] [Related]
19. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of osthole inhibition of vascular Ca(v)1.2 current. Fusi F; Sgaragli G; Ha le M; Cuong NM; Saponara S Eur J Pharmacol; 2012 Apr; 680(1-3):22-7. PubMed ID: 22329900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]